ICON (ICLR)
(Delayed Data from NSDQ)
$164.80 USD
-1.64 (-0.99%)
Updated Aug 4, 2025 04:00 PM ET
After-Market: $164.86 +0.06 (0.04%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, ICON PLC has a PEG ratio of 2.15 compared to the Medical Services industry's PEG ratio of 1.45.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ICLR 164.80 -1.64(-0.99%)
Will ICLR be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ICLR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ICLR
Icon PLC (ICLR) Q2 Earnings and Revenues Top Estimates
Labcorp Holdings (LH) Earnings Expected to Grow: Should You Buy?
ICLR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Analysts Estimate Icon PLC (ICLR) to Report a Decline in Earnings: What to Look Out for
Tempus AI's Data Business Keeps Scaling Up: Can the Growth Pace Last?
Here's Why You Should Retain ICLR Stock in Your Portfolio Now
Other News for ICLR
ClearBridge Mid Cap Portfolios Q2 2025 Commentary
ClearBridge Large Cap Growth Fund Q2 2025 Commentary
ICLR Stock Update: UBS Raises Price Target to $240 While Maintaining Buy Rating | ICLR Stock News
ICLR: Truist Securities Raises Price Target for Icon to $234 | ICLR Stock News
ICLR: Barclays Raises Price Target for Icon | ICLR Stock News